SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-086117
Filing Date
2018-03-19
Accepted
2018-03-16 18:05:08
Documents
5
Period of Report
2018-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d553849d8k.htm 8-K 18025
2 EX-1.1 d553849dex11.htm EX-1.1 201687
3 EX-5.1 d553849dex51.htm EX-5.1 4915
4 GRAPHIC g553849img01.jpg GRAPHIC 15845
5 GRAPHIC g553849img04.jpg GRAPHIC 8125
  Complete submission text file 0001193125-18-086117.txt   259021
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36282 | Film No.: 18696937
SIC: 2836 Biological Products, (No Diagnostic Substances)